Hilzinger Kurt J disclosed buy in Outlook Therapeutics, Inc.
Hilzinger Kurt J buy $176.5K of disclosed value in Outlook Therapeutics, Inc..
Signal
Insider Trade
Action
Buy
Capital
$176.5K disclosed value
Why it matters
Insider Form 4 disclosures can surface management and director trading activity. This card is generated from canonical action facts, not request-time scraping.